Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned subsidiary, Pivot Naturals LLC, has entered into a binding Letter of Intent (“LOI”) with Healthcare Options for Patients Enterprises LLC, dba HOPE Cannabis Products (“HOPE”). HOPE is fully licensed to manufacture, distribute and sell cannabis products in Nevada, offering products such as effect-based vape cartridges, syringes, micro-dosed oral sprays, pre-rolls, infused pre-rolls, infused cold brew coffee and infused lemonade. Per the LOI, HOPE will manufacture and distribute Pivot Naturals’ product line in Nevada and Pivot will manufacture and distribute HOPE’s product line in California. Definitive agreements, anticipated to be completed before August 31, 2018, will include a non-exclusive license grant to HOPE to commercialize Pivot’s Ready-To-Infuse Cannabis (“RTIC”) powder technology, only in Nevada. A manufacturing agreement is anticipated as well, detailing the plans for Pivot to manufacture HOPE’s products at Pivot’s facility in Costa Mesa, California (pending receipt of appropriate licenses), and for HOPE to manufacture Pivot’s products at HOPE’s licensed manufacturing facility in Las Vegas, Nevada.
“I am thrilled that we have partnered with such an ethical and forward-thinking company. This partnership not only monetizes the RTIC technology, but validates our strategy to formulate unique and differentiated products. Dr. Rubin and his team understand our vision of creating the best science-based health and wellness biocannabis products for consumers. Upon execution of these agreements, Pivot will be well positioned to generate significant revenues in the State of Nevada, and with California coming online in Q4 2018, we now have access to two of the largest cannabis markets in the U.S,” Pivot Naturals president Patrick J. Rolfes stated in the news release.
To view the full press release, visit http://ibn.fm/gQymR
About Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. Pivot’s wholly-owned U.S. subsidiary, Pivot Naturals, LLC, based in Costa Mesa, California, will manufacture and supply finished powderized cannabis products such as food additives, capsules, bulk powder and stick packs to the California market. PGS has acquired worldwide rights to Ready-To-Infuse Cannabis (“RTIC”) oil-to-powder technology, BiPhasix™ Dermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol (“CBD”), and tetrahydrocannabinol (“THC”)-based products. For more information, visit the company’s website at www.PivotPharma.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php